Latest News
SELLAS Life Sciences Shares Slide 3.9% as Dilution Concerns Weigh on Valuation
SELLAS Life Sciences shares dropped 3.9% on Monday as the latest share count of 196.6 million suggests a $2.14 billion market cap, 14% above the live feed. The biotech awaits final REGAL trial data.
Shopify Jumps 10% as Payments Drive Growth, Margins Under Scrutiny
Shopify shares jumped 10.2% as payments drove 84% of merchant-solutions revenue growth, but margin compression and rising transaction losses tempered investor enthusiasm.
AMD Shares Tumble 7% on Delayed Helios Launch and Valuation Concerns
AMD shares dropped 7% to $485.66, losing roughly $60 billion in market cap, after the company's delayed Helios AI chip launches raised concerns about its high valuation.
Oracle Stock Recovers on $7B Pentagon Deal, AI Spending Concerns Linger
Oracle shares climbed 4.6% on a Pentagon deal worth up to $7 billion, but the annual cap is modest relative to revenue and AI spending pressures remain.
AMC Stock Rises on Record IMAX Revenue, But Dilution Woes Linger
AMC shares rose 3.1% following record IMAX revenue from 'The Odyssey,' but a 67% rise in diluted shares raises concerns about cash flow and shareholder value.






